Project Grant R15NS137286

Award Date 9/23/24
Completion Date 8/31/27
Dollars Obligated $408K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Stephenville, TX 76402, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on developing novel methods for selectively stimulating nociceptors (pain receptors) and measuring the brain's nociceptive-specific response in both healthy individuals and those with the chronic pain condition fibromyalgia. The $2,314,276 award to Emory University will fund the creation of a new...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $560,934 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research on neural coding and control of pain detection in the somatosensory cortex. The 5-year research project, which commenced on April 1, 2025, aims to: Define...
This $168,438 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, will support a research project to characterize the phenotypic and neurophysiological features of cognitive dysfunction in individuals with fibromyalgia. The key objectives are to: 1) Compare subjective and objective cognitive assessments between individuals with fibromyalgia and healthy...
This federal Project Grant award of $231,000.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to determine whether electrical stimulation of distinct subregions within the human insula can differentially modulate sensory and higher-order, integrative aspects of pain processing. The research aims to provide proof-of-concept that multi-site insula...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,365,011 to the University of Washington to conduct a clinical trial examining the neuromodulatory mechanisms and moderators of mindfulness meditation (MM) and self-hypnosis (HYP) for chronic pain reduction in older adults. The study will enroll 375 participants and use arterial spin labeling fMRI and EEG to investigate how these non-pharmacological treatments impact chronic pain via...
This federal Project Grant award in the amount of $351,097 was provided by the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH). The grant was awarded under the NIH's Drug Use and Addiction Research Programs (CFDA 93.279) to establish a rigorous and supportive interdisciplinary training program in clinical pain research at Mass General Brigham (MGB) in Boston. The program will support a diverse pool of 8 postdoctoral...
This federal Project Grant award of $129,113 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the SPARQ: Summer Program to Advance Research and Equity in Pain and Neurological Health at Seattle Children's Hospital. The 9-week program aims to expose 10 undergraduate students per year to rigorous, interdisciplinary pain and neuroscience research, with a...
This $158,502 federal Project Grant award from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports the acquisition of an electroencephalogram (EEG) system at the University of South Carolina Aiken (USCA). The EEG system will advance multi-user interdisciplinary neuroscience research across USCA's psychology, biology, nursing, business, exercise science, and computer/engineering departments. Key planned research activities include examining neural...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $2,884,007 to the University of California, San Diego (UCSD) to investigate mechanisms of intra- and inter-individual pain variability in patients with comorbid chronic low back pain (CLBP) and major depressive disorder (MDD). The research aims to generate individualized prediction models of momentary pain intensity using ecological momentary...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $441,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Duquesne University of the Holy Spirit. The purpose of this 3-year grant, beginning September 2023, is to utilize laboratory data and computational 3-D modeling to analyze the role of the central amygdala in neuropathic pain. Specifically, the project aims to build a proof-of-concept 3-D...

This $408,000 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program supports research to provide a comprehensive EEG profile of the cortical activity underlying the cognitive processing of the sensory-discriminative and affective-motivational dimensions of osteoarthritis knee pain. The research, conducted by Tarleton State University, aims to elucidate the neural oscillations associated with the multidimensional pain experience, which could yield insights into pain physiology and identify novel treatment targets. The project will utilize a robust methodological approach, including full-frequency band EEG analysis from all electrodes, coherence, absolute and overall power, in a large sample of participants with chronic knee pain and sex-matched controls. This federally-funded research is expected to generate novel and meaningful findings, even if the original hypotheses are not supported, due to the rigorous study design.

Generated 7/1/25, 5:30 AM